By systemic application of comprehensive systems biology approaches, we narrowed down the potential gene list for EO-IBD to allelic variants in ITGAV (G458V) and FN1 (G313V) genes, which are involved in a range of immune cell activities, including T cell and regulatory pathways, as well as B cell development pathways. The gene discussed is FN1; the disease is inflammatory bowel disease.